A new cytochemical method for in situ detection of cholinergic synaptic transmission by staining of Cu2+ incorporated in frog neuromuscular junction during nerve stimulation.
A new cytochemical method was devised in order to visualize Cu2+ ions in the synaptic area after their intracellular penetration during nerve stimulation of the frog neuromuscular junction (NMJ). The motor nerves were stimulated in presence of Cu2+. After total blockade of the neuromuscular junction, the tissue was treated by ferrocyanide, a precipitating agent of Cu2+, and fixed for optical and electron microscopic observation. The oxidoreductase-like catalytic activity of the copper ferrocyanide precipitate was used to amplify the cytochemical staining by a treatment with diaminobenzidine and H2O2, after permeabilization of cell membranes by Triton X-100. At optical level, an intense staining was observed in the synaptic area. Application of d-tubocurarine (d-TC), a selective inhibitor of nicotinic acetylcholine receptors (nAChRs), markedly reduced the staining. No reaction could be observed in absence of membrane permeabilization. These results suggest that Cu2+ was localized in the cytoplasm of muscle cells after its penetration through nAChRs. At electron microscopic level, cytochemical reaction was found in the cytoplasm of muscle cells near the postsynaptic membrane, and in a few synaptic vesicles in the vicinity of the active zone. This method may be used for the identification of cholinergic inputs in central and peripheral nerve systems and, generally speaking, for the detection of synaptic activity elicited by specific nerve stimulation.
Hirai
Keiji
K
Department of Autonomic Physiology, Medical Research Institute, Tokyo Medical and Dental University, Japan.
Tanaka
Eiichiro
E
Motelica-heino
Ion
I
Katayama
Yoshifumi
Y
Higashi
Hideo
H
Tsuji
Shigeru
S
D015100:3,3'-Diaminobenzidine / Q000494:pharmacology; D000818:Animals; D003300:Copper / Q000378:metabolism / Q000494:pharmacology*; D003593:Cytoplasm / Q000378:metabolism; D003902:Detergents / Q000494:pharmacology; D005295:Ferrocyanides / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007150:Immunohistochemistry; D008854:Microscopy, Electron; D009469:Neuromuscular Junction / Q000473:pathology*; D009474:Neurons / Q000378:metabolism*; D018733:Nicotinic Antagonists / Q000494:pharmacology; D017830:Octoxynol / Q000494:pharmacology; D011898:Ranidae; D011978:Receptors, Nicotinic / Q000378:metabolism*; D009435:Synaptic Transmission
D003902:Detergents; D005295:Ferrocyanides; D018733:Nicotinic Antagonists; D011978:Receptors, Nicotinic; D015100:3,3'-Diaminobenzidine; D003300:Copper; D017830:Octoxynol; D006861:Hydrogen Peroxide; C020354:hexacyanoferrate II